Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ RALGAPA2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5101287

Catalog No. PIPA5101287


Only null left
Add to Cart

Description

Description

Antibody detects endogenous levels of total AS250.

Catalytic subunit of the heterodimeric RalGAP2 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

RALGAPA2
Polyclonal
Unconjugated
RALGAPA2
250 kDa substrate of Akt; A230067G21Rik; akt substrate AS250; AS250; bA287B20.1; BC053994; C20orf74; dJ1049G11; dJ1049G11.4; Kiaa1272; p220; pp250; Ral GTPase activating protein catalytic alpha subunit 2; Ral GTPase activating protein, alpha subunit 2 (catalytic); ral GTPase-activating protein alpha subunit 2; ral GTPase-activating protein subunit alpha-2; RALGAPA2; RapGAPalpha2; RGC2
Rabbit
Affinity chromatography
RUO
241694, 57186
-20°C
Liquid
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry
1 mg/mL
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
A3KGS3, Q2PPJ7
RALGAPA2
A synthesized peptide derived from human RALGAPA2(Accession Q2PPJ7), corresponding to amino acid residues S646-S696.
100 μL
Primary
Human, Mouse
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.